EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrative Network Pharmacology Study of Cordyceps militaris Compounds for Prostate Cancer Treatment

Sarah Cecilia Astrid Laihad, Trina Ekawati Tallei, Lydia Estelina Naomi Tendean, Grace Lendawati Amelia Turalaki, Sylvia Ritta Marunduh, Diana Shintawati Purwanto, Billy Johnson Kepel, Abdul Hawil Abas

Heca Journal of Applied Sciences · 30.03.2026 · 4 (1) · 70-87

DOI: 10.60084/hjas.v4i1.382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heca Journal of Applied Sciences, online erschienen am 30.03.2026. Verfasst von Sarah Cecilia Astrid Laihad und 7 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer remains one of the leading causes of cancer-related mortality in men, while adverse effects and the development of drug resistance often limit current therapeutic strategies. Natural products have gained increasing attention as potential sources of novel anticancer agents due to their multitarget properties and relatively low toxicity. Cordyceps militaris, a medicinal fungus rich in bioactive compounds, has been reported to exhibit anticancer activity; however, its compound-target interactions in prostate cancer have not been comprehensively elucidated. This study aimed to explore the interactions between C. militaris bioactive compounds and prostate cancer-associated targets using a pharmacology network-based in silico approach. A total of 50 bioactive compounds were collected from metabolite profiling studies, of which 19 compounds were selected based on high predicted TP53 expression enhancer activity (Pa ≥ 0.7) using WAY2DRUG PASS analysis. Protein targets were predicted using SwissTargetPrediction and the Similarity Ensemble Approach, and then intersected with prostate cancer-associated proteins retrieved from GEPIA2, GeneCards, and OMIM, yielding 499 overlapping targets. Protein interaction network analysis was performed using STRING and visualized in Cytoscape, enabling the identification of key hub proteins based on the applied parameters, highlighting ten key proteins, including SRC, ESR1, MAPK1, AKT1, HSP90AA1, MAPK3, HSP90AB1, EGFR, GRB2, and PRKACA, within the interaction network. Pathway enrichment analysis indicated that these targets were predominantly involved in cancer-associated signaling pathways, such as the EGFR tyrosine kinase inhibitor resistance pathway. Furthermore, the results revealed that the selected compounds interact with these key prostate cancer-associated proteins. Pharmacokinetic and toxicity evaluation predicted favorable drug-likeness and acceptable safety profiles for selected compounds. Overall, this study highlights the potential of C. militaris bioactive compounds as promising alternative for prostate cancer through multitarget modulation of clinically relevant signaling pathways. Further experimental validation is still required to confirm these findings.

Zitieren

APA

Laihad, S. C. A., Tallei, T. E., Tendean, L. E. N., Turalaki, G. L. A., Marunduh, S. R., Purwanto, D. S., Kepel, B. J., & Abas, A. H. (2026). Integrative Network Pharmacology Study of Cordyceps militaris Compounds for Prostate Cancer Treatment. Heca Journal of Applied Sciences, 4(1), 70-87. https://doi.org/10.60084/hjas.v4i1.382

Vancouver

Laihad SCA, Tallei TE, Tendean LEN, Turalaki GLA, Marunduh SR, Purwanto DS, et al. Integrative Network Pharmacology Study of Cordyceps militaris Compounds for Prostate Cancer Treatment. Heca Journal of Applied Sciences. 2026;4(1):70-87. doi:10.60084/hjas.v4i1.382

BibTeX
@article{Laihad2026,
  author = {Laihad, Sarah Cecilia Astrid and Tallei, Trina Ekawati and Tendean, Lydia Estelina Naomi and Turalaki, Grace Lendawati Amelia and Marunduh, Sylvia Ritta and Purwanto, Diana Shintawati and Kepel, Billy Johnson and Abas, Abdul Hawil},
  title = {Integrative Network Pharmacology Study of Cordyceps militaris Compounds for Prostate Cancer Treatment},
  journal = {Heca Journal of Applied Sciences},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {70--87},
  doi = {10.60084/hjas.v4i1.382}
}
Kostenlos starten →